The role of fibroblasts in tissue engineering and regeneration

British Journal of Dermatology

Volumn 156, Issue 6, 2007, Pages 1149-1155

  Wong, T ^a   McGrath, J A ^a   Navsaria, H ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Burns; Cell culture; Dermis; Skin; Ulcer; Wound healing

Indexed keywords

ALLODERM; COLLAGEN TYPE 7; CORTICOSTEROID; CYCLOSPORIN A; UNCLASSIFIED DRUG;

BURN; CELL BASED GENE THERAPY; CELL CULTURE; CELL INTERACTION; CULTURE TECHNIQUE; CYTOLOGY; DECUBITUS; DERMATOLOGY; EPIDERMOLYSIS BULLOSA; EPITHELIUM CELL; ESTHETIC SURGERY; FIBROBLAST; GENODERMATOSIS; HUMAN; MESENCHYME CELL; NONHUMAN; PLASTIC SURGERY; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; REVIEW; SKIN ALLOGRAFT; SKIN AUTOGRAFT; SKIN FIBROBLAST; TISSUE ENGINEERING; TISSUE REGENERATION; ULCER; WOUND HEALING;

CULTURE TECHNIQUES; FEMALE; FIBROBLASTS; HUMANS; MALE; RECONSTRUCTIVE SURGICAL PROCEDURES; SKIN, ARTIFICIAL; TISSUE ENGINEERING; WOUND HEALING;

EID: 34447103624     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.07914.x     Document Type: Review

References (59)

1. Chang HY, Chi JT, Dudoit S et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A 2002 99 : 12877 82.
2. Clark RAF. Wound repair: overview and general considerations. In : The Molecular and Cellular Biology of Wound Repair (Clark RAF, ed.). New York, NY : Plenum Press, 1996 3 35.
3. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975 6 : 331 4.
4. Navsaria A, Myers SR, Leigh I et al. Culturing skin in vitro for wound therapy. Trends Biotechnol 1995 13 : 91 100.
5. Schneider EL, Mitsui Y. The relationship between in vitro cellular aging and in vivo human age. Proc Natl Acad Sci U S A 1976 73 : 3584 8.
6. Phillips CL, Combs SB, Pinnell SR. Effects of ascorbic acid on proliferation and collagen synthesis in relation to the donor age of human dermal fibroblasts. J Invest Dermatol 1994 103 : 228 32.
7. Woan KV, Narain NR, Persaud I et al. Coenzyme Q10 enhances the proliferation and migration of fibroblasts and keratinocytes: a possible implication for wound healing. J Invest Dermatol 2005 124s : A57.
8. Bello YM, Falabella AF, Eaglstein WH. Tissue-engineered skin. Current status in wound healing. Am J Clin Dermatol 2001 2 : 305 13.
9. Nanchahal J, Ward CM. New grafts for old? A review of alternatives to autologous skin. Br J Plast Surg 1992 45 : 354 63.
10. Lamme EN, van Leeuwen RT, Mekkes JR et al. Allogeneic fibroblasts in dermal substitutes induce inflammation and scar formation. Wound Repair Regen 2002 10 : 152 60.
11. Morimoto N, Saso Y, Tomihata K et al. Viability and function of autologous and allogeneic fibroblasts seeded in dermal substitutes after implantation. J Surg Res 2005 125 : 56 67.
12. Price RD, Das-Gupta V, Harris PA et al. The role of allogenic fibroblasts in an acute wound healing model. Plast Reconstr Surg 2004 113 : 1719 29.
13. Griffiths M, Ojeh N, Livingstone R et al. Survival of Apligraf in acute human wounds. Tissue Eng 2004 10 : 1180 95.
14. Falanga V, Margolis D, Alvarez O et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol 1998 134 : 293 300.
15. Theobald VA, Lauer JD, Kaplan FA et al. 'Neutral allografts'- lack of allogeneic stimulation by cultured human cells expressing MHC class I and class II antigens. Transplantation 1993 55 : 128 33.
16. Phillips TJ, Manzoor J, Rojas A et al. The longevity of a bilayered skin substitute after application to venous ulcers. Arch Dermatol 2002 138 : 1079 81.
17. Aoki S, Toda S, Ando T et al. Bone marrow stromal cells, preadipocytes and dermal fibroblasts promote epidermal regeneration in their distinctive fashions. Mol Biol Cell 2004 15 : 4647 57.
18. El-Ghalbzouri A, Gibbs S, Lamme E et al. Effect of fibroblasts on epidermal regeneration. Br J Dermatol 2002 147 : 230 43.
19. Igarashi A, Okochi H, Bradham DM, Grotendorst GR. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 1993 4 : 637 45.
20. Boxman I, Lowik C, Aarden L, Ponec M. Modulation of IL-6 production and IL-1 activity by keratinocyte-fibroblast interaction. J Invest Dermatol 1993 101 : 316 24.
21. Marchese C, Felici A, Visco V et al. Fibroblast growth factor 10 induces proliferation and differentiation of human primary cultured keratinocytes. J Invest Dermatol 2001 116 : 623 8.
22. Werner S, Smola H. Paracrine regulation of keratinocyte proliferation and differentiation. Trends Cell Biol 2001 11 : 143 6.
23. Blomme EA, Sugimoto Y, Lin YC et al. Parathyroid hormone-related protein is a positive regulator of keratinocyte growth factor expression by normal dermal fibroblasts. Mol Cell Endocrinol 1999 152 : 189 97.
24. Mass-Szabowski N, Shimotoyodome A, Fusenig NE. Keratinocyte growth regulation in fibroblast cocultures via a double paracrine mechanism. J Cell Sci 1999 112 : 1843 53.
25. Marinkovich MP, Keene DR, Rimberg CS. Cellular origin of the dermal-epidermal basement membrane. Dev Dyn 1993 197 : 244 67.
26. Kahari VM, Peltonen J, Chen Y et al. Differential modulation of basement membrane gene expression in human fibrosarcoma HT-1080 cells by transforming growth factor-beta 1. Enhanced type IV collagen and fibronectin gene expression correlates with altered culture phenotype of the cells. Lab Invest 1991 64 : 807 18.
27. Konig A, Bruckner-Tuderman L. Transforming growth factor-beta stimulates collagen VII expression by cutaneous cells in vitro. J Cell Biol 1992 117 : 679 85.
28. Trompezinski S, Berthier-Vergnes O, Denis A et al. Comparative expression of vascular endothelial growth factor family members, VEGF-B, -C and -D by normal human keratinocytes and fibroblasts. Exp Dermatol 2004 13 : 98 105.
29. Bauer SM, Bauer RJ, Liu Z-J et al. Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis and collagen constriction in three-dimensional collagen gels. J Vasc Surg 2005 41 : 699 707.
30. Yamaguchi Y, Hearing VJ, Satoshi I et al. Mesenchymal-epithelial interactions in the skin: aiming for site-specific tissue regeneration. J Dermatol Sci 2005 40 : 1 9.
31. Fimiani M, Pianigiani E, Cherubini F et al. Other uses of homologous skin grafts and skin bank bioproducts. Clin Dermatol 2005 23 : 396 402.
32. Mansbridge J. Commercial considerations in tissue engineering. J Anat 2006 209 : 527 32.
33. Brem H, Balledux J, Bloom T et al. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent. Arch Surg 2000 135 : 627 34.
34. Mostow EN. Diagnosis and classification of chronic wounds. Clin Dermatol 1994 12 : 3 9.
35. Brem H, Young J, Tomic-Canic M et al. Clinical efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of diabetic foot ulcers. Surg Technol Int 2003 11 : 23 31.
36. Kubo K, Kuroyanagi Y. A study of cytokines released from fibroblasts in cultured dermal substitute. Artif Organs 2005 29 : 845 9.
37. Kirsner RS, Falanga V, Eaglstein WH. The development of bioengineered skin. Trends Biotechnol 1998 16 : 246 9.
38. Stanley AC, Park HY, Phillips TJ et al. Reduced growth of dermal fibroblasts from chronic venous ulcers can be stimulated with growth factors. J Vasc Surg 1997 26 : 994 9.
39. Kim BC, Kim HT, Park SH et al. Fibroblasts from chronic wounds show altered TGF-beta signaling and decreased TGF-beta type II receptor expression. J Cell Physiol 2003 195 : 331 6.
40. Loots MA, Lamme EN, Mekkes JR et al. Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin dependent diabetes mellitus) show disturbed proliferation. Arch Dermatol Res 1999 291 : 93 9.
41. Jones JE, Nelson EA. Skin grafting for venous leg ulcers. Cochrane Database Syst Rev 2005 25 : CD001737.
42. Marston WA, Hanft J, Norwood P et al. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 2003 26 : 1701 5.
43. Burd A, Chiu T. Allogeneic skin in the treatment of burns. Clin Dermatol 2005 23 : 376 87.
44. Atiyeh BS, Hayek SN, Gunn SW. New technologies for burn wound closure and healing - review of the literature. Burns 2005 31 : 944 56.
45. Alexander JW, MacMillan BG, Law E et al. Treatment of severe burns with widely meshed skin autografts and meshed skin allograft overlay. J Trauma 1981 21 : 433 8.
46. Waymack P, Duff RG, Sabolinski M et al. The effect of a tissue engineered bilayered living skin analog, over meshed split-thickness autografts on the healing of excised burn wounds. Burns 2000 26 : 609 19.
47. Eisenberg M, Llewelyn D. Surgical management of hands in children with recessive dystrophic epidermolysis bullosa: use of allogeneic composite cultured skin grafts. Br J Plast Surg 1998 51 : 608 13.
48. Falabella AF, Valencia IC, Eaglstein WH et al. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol 2000 136 : 1225 30.
49. Fivenson DP, Scherschun L, Choucair M et al. Graftskin therapy in epidermolysis bullosa. J Am Acad Dermatol 2003 48 : 886 92.
50. Goto M, Sawamura D, Ito K et al. Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa. J Invest Dermatol 2006 126 : 766 72.
51. Woodley DT, Krueger GG, Jorgensen CM et al. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone. J Invest Dermatol 2003 121 : 1021 8.
52. Huang Y, Hou YP, Bak R et al. Intravenously injected gene-corrected dystrophic epidermolysis bullosa (DEB) fibroblasts home to skin wounds: implications for DEB treatment. J Invest Dermatol 2005 124s : A81.
53. de Imus G, Golomb C, Wilkel C et al. Accelerated healing of pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppression. J Am Acad Dermatol 2001 44 : 61 6.
54. Flores F, Eaglstein WA, Kirsner RS. Hydroxyurea-induced leg ulcers treated with Apligraf. Ann Int Med 2000 132 : 417 18.
55. Martin LK, Kirsner RS. Ulcers caused by bullous morphoea treated with tissue-engineered skin. Int J Dermatol 2003 42 : 402 4.
56. Streit M, Bohlen LM, Braathen LR. Ulcerative sarcoidosis successfully treated with Apligraf. Dermatology 2001 202 : 367 70.
57. Gath HJ, Hell B, Zarrinbal R et al. Regeneration of intraoral defects after tumour resection with a bioengineered human dermal replacement (Dermagraft). Plast Reconstruct Surg 2002 109 : 889 93.
58. Gohari S, Gambla C, Healey M et al. Evaluation of tissue-engineered skin (human skin substitute) and secondary intention healing in the treatment of full thickness wounds after Mohs micrographic or excisional surgery. Dermatol Surg 2002 28 : 1107 14.
59. Watson D, Keller GS, Lacombe V et al. Autologous fibroblasts for treatment of facial rhytids and dermal depressions. Arch Facial Plast Surg 1999 1 : 165 70.